BK2069 Biotechnology
- 4317.108
- +81.618+1.93%
Form 144 | Tango Therapeutics(TNGX.US) Insider Proposes to Sell 577.5K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $Tango Therapeutics(TNGX.US)$ Insider MVA Investors, LLC intends to sell 75,000 shares of its common stock on May 1, with a total market value of approximately $577.5K.
Express News | Astellas Pharma: Poseida Is Eligible for up to Low Double Digit Tiered Royalties as a Percentage of Net Sales
Express News | Astellas Pharma: Poseida Will Receive Contingency Payments of up to US $550 Million in Total
Express News | Astellas Pharma: Poseida Will Receive US $50 Million Upfront Plus Potential Development and Sales Milestones
Aadi Biosciences(AADI.US) Officer Sells US$77,184 in Common Stock
$Aadi Biosciences(AADI.US)$ Officer Desai Neil sold 40,000 shares of common stock on May 1, 2024 at an average price of $1.9296 for a total value of $77,184.Source: Announcement What is statement of c
Express News | Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Mesoblast Shareholder Voting Power Shifts
Earnings Call: United Therapeutics Reports Strong Q1 With Record Revenue
Immutep's Innovative Cancer Therapy Shows Promise
Ardelyx(ARDX.US) Officer Sells US$192.06K in Common Stock
$Ardelyx(ARDX.US)$ Officer RAAB MICHAEL sold 30,000 shares of common stock on Apr 29, 2024 at an average price of $6.4019 for a total value of $192.06K.Source: Announcement What is statement of change
Chimeric Therapeutics Appoints COO; Shares Rise 4%
Chimeric Therapeutics (ASX:CHM) appointed Rebecca McQualter as its chief operating officer, the clinical stage cell therapy company said Thursday. McQualter has previously worked at companies such as
Morphic Ethical Equities Continues Share Buy-Back
BeiGene (06160.HK) issued 155,900 shares due to restricted share units
On May 2, GLONGHUI (06160.HK) issued an announcement. On April 30, 2024, 155,900 common shares will be issued due to the ownership of restricted share units granted under the equity plan (excluding company directors).
BeiGene (06160) issued 261.82 million shares under the share award scheme on April 30
According to the Zhitong Finance App, BeiGene (06160) announced that 261.82 million shares will be issued under the share award program on April 30, 2024.
Aileron Therapeutics(ALRN.US) 10% Shareholder Sells US$139.1K in Common Stock
$Aileron Therapeutics(ALRN.US)$ 10% Shareholder UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO sold 31,151 shares of common stock on Apr 29, 30, May 1, 2024 at an average price of $4.465 for a
Enliven Therapeutics(ELVN.US) Officer Sells US$214.99K in Common Stock
$Enliven Therapeutics(ELVN.US)$ Officer Lyssikatos Joseph P sold 12,000 shares of common stock on Apr 29, 2024 at an average price of $17.9156 for a total value of $214.99K.Source: Announcement What i
Enliven Therapeutics(ELVN.US) Officer Sells US$55,164.53 in Common Stock
$Enliven Therapeutics(ELVN.US)$ Officer Hohl Benjamin sold 3,250 shares of common stock on Apr 29, 2024 at an average price of $16.9737 for a total value of $55,164.53.Source: Announcement What is sta
AEterna Zentaris To Carry Out 1-for-4 Reverse Stock Split On May 3rd, 2024
May 2nd - $AEterna Zentaris(AEZS.US)$ is about to implement a 1-for-4 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 3rd, 2024.$AEterna Zentaris(AEZS.U
Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Earnings Call Summary | United Therapeutics(UTHR.US) Q1 2024 Earnings Conference
The following is a summary of the United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript:Financial Performance:United Therapeutics reported a record Q1 revenue of $678 million, a grow